News | October 31, 2025
BMS’ Cobenfy sees steady start, eyes stronger growth ahead
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Subscribe To Our Newsletter & Stay Updated
